1. Singer, A., Time and truth for cancer vaccines—a new generation. J. Natl. Cancer Inst. 86, 330–330 (1994).
2. Kawakami, Y. et al. Cloning of the gene coding for a shared human-melanoma anti-gen recognized by autologous T-cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91, 3515–3519 (1994).
3. Disis, M.L., Smith, J.W., Murphy, A.E., Chen, W., & Cheever, M.A. In vitro generation of human CTL specific for peptides derived from the Her-2/neu protooncogene pro-tein. Cancer Res. 54, 1071–1076 (1994).
4. Theobald, M., Biggs, J., Dittmer, D., Levine, A.J. & Sherman, L.A. Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. USA 92, 11993–11997 (1995).
5. Schendel, D.J. & Gansbacher, B. Tumor specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: Modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Cancer Res. 53, 4020–4025 (1993).